-
Adjunctive Argatroban or Eptifibatide Shows No Benefit with Thrombolysis in Thrombectomy Patients: JAMA
26 Aug 2025 07:20 GMT
… American Medical Association revealed that adding argatroban or … Stroke Thrombolysis (MOST) trial was conducted between 2019 … the addition of either drug compared to placebo. … Investigators. (2025). Intravenous argatroban or eptifibatide in patients undergoing …
-
Lipid-Lowering Effects Discovered in FDA-Approved Drugs Using Machine Learning
09 Aug 2025 16:36 GMT
… before and after medication, 4 drugs—argatroban (Acova), levothyroxine sodium … Bayer), prasterone (Intrarosa; Cosette Pharmaceuticals), and regorafenib (Stivarga; Bayer … results of this trial provide a multitude … A Meta-Analysis of Statin Trials. JACC. 2014;64 …
-
Machine Learning Predicts Lipid Lowering Potential in FDA Approved Drugs
30 Jul 2025 16:54 GMT
… Southern Medical University and collaborators report the identification of FDA‑ … highlight possible mechanisms
Seven promising drugs (Argatroban, Promega, sulfaphenazole, sorafenib, … to humans. Randomized controlled trials and biochemical studies are …
-
FDA Clears INTRABEAM 700 as Supportive Device for Intraoperative Radiation Therapy
29 Apr 2025 11:11 GMT
… the FDA has given clearance to ZEISS Medical’s INTRABEAM … efficient treatment workflow.
READ MORE: Argatroban Plus Dual Antiplatelet Treatment Proves … several large-scale clinical trials investigating IORT in … phase 3 INTRAGO-II trial of glioblastoma (data …
-
Argatroban Plus Dual Antiplatelet Treatment Proves Effective in Branch Atherosclerosis Disease
27 Apr 2025 18:59 GMT
… a recently published randomized controlled trial, treatment with argatroban plus dual antiplatelet therapy … 2 treatment groups, 20.4% (n = 10) of patients on argatroban plus …
-
Adjunctive treatment with argatroban or eptifibatide does not improve post-stroke functional outcomes
02 Oct 2024 16:30 GMT
… In this randomized controlled trial, among ischemic stroke … argatroban, an anticoagulant, or eptifibatide, an antiplatelet. However, other trials … which favored the treatment group showing greater benefit … the most from enhanced medical reperfusion, could have …
-
Adjunctive Argatroban and Eptifibatide Fails to Show Benefit in Reducing Poststroke Disability in Phase 3 Study
12 Sep 2024 18:05 GMT
… treatment with intravenous argatroban, an anticoagulant agent, or eptifibatide (Integrillin; Millennium Pharmaceuticals …
“Without negative trials, we would … neurosurgery, McGovern Medical School at … clotting drugs to stroke care ineffective, clinical trial …
-
Adjunctive Argatroban or Eptifibatide in Acute Stroke Increases Mortality
12 Sep 2024 11:00 GMT
… of Emergency Medicine by Adeoye et al.
The standard treatment of acute … conducted a clinical trial to compare the effects of argatroban, eptifibatide, and … (8%).
They concluded adjunctive treatment with argatroban or eptifibatide did not improve …
-
WashU Medicine finds anti-clotting drugs fail to improve stroke care outcomes
05 Sep 2024 12:22 GMT
… Medicine) in the US have found that adding anti-clotting stroke drugs … trial evaluated the efficacy of argatroban and eptifibatide alongside routine intravenous thrombolysis treatment.
Argatroban …
The trial was spearheaded by WashU Medicine department …
-
Combining Argatroban or Eptifibatide with Thrombolysis Does Not Benefit Stroke Patients: NEJM
17 Sep 2024 20:36 GMT
… England Journal of Medicine revealed that the addition of argatroban, an anticoagulant … standard treatment for acute ischemic stroke, this trial demonstrates that adding argatroban or … 9, pp. 810–820). Massachusetts Medical Society. https://doi …